PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30254491-2	2018	Palbociclib is a putative novel DIPG treatment that restricts the proliferation of rapidly dividing cancer cells via selective inhibition of cyclin-dependent kinase (CDK) 4 and CDK6.	Dipinacoline glutamate	32-36	cyclin dependent kinase 4	Homo sapiens	141-172	
30254491-12	2018	Conclusion: These data illustrate the in vitro antiproliferative effects of CDK4/6 and mTOR inhibitors in DIPG cells.	Dipinacoline glutamate	106-110	cyclin dependent kinase 4	Homo sapiens	76-82